Erythromycin Base



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 68.7%
Product Used For Unknown Indication 6.9%
Infection 4.1%
Pneumonia 2.6%
Hypertension 1.9%
Acne 1.7%
Bronchitis 1.7%
Pain 1.4%
Rosacea 1.4%
Ear Infection 1.2%
Lower Respiratory Tract Infection 1.2%
Sinusitis 1.2%
Hormone Replacement Therapy 1.0%
Blood Cholesterol Increased 0.7%
Blood Pressure 0.7%
Dry Skin 0.7%
Pharyngitis Streptococcal 0.7%
Premature Rupture Of Membranes 0.7%
Prophylaxis Against Gastrointestinal Ulcer 0.7%
Upper Respiratory Tract Infection 0.7%
Rash 20.3%
Vomiting 17.1%
Nausea 9.8%
Urticaria 8.9%
Hypersensitivity 7.3%
Palpitations 3.3%
Swelling 3.3%
Swelling Face 3.3%
Syncope 3.3%
Wheezing 3.3%
Abdominal Discomfort 2.4%
Drug Toxicity 2.4%
Hepatic Enzyme Increased 2.4%
Pruritus 2.4%
Unevaluable Event 2.4%
Abdominal Pain Upper 1.6%
Adverse Drug Reaction 1.6%
Diarrhoea 1.6%
Drug Ineffective 1.6%
Hallucination, Visual 1.6%
Secondary
Product Used For Unknown Indication 25.7%
Drug Use For Unknown Indication 16.2%
Pneumonia 12.2%
Drug Exposure During Pregnancy 5.4%
Hormone Replacement Therapy 5.4%
Bronchitis 4.1%
Lower Respiratory Tract Infection 4.1%
Xanthomatosis 4.1%
Ear Infection 2.7%
Hypertension 2.7%
Infection 2.7%
Rosacea 2.7%
Tooth Infection 2.7%
Antibiotic Prophylaxis 1.4%
Cough 1.4%
Dental Cleaning 1.4%
Dermatitis Contact 1.4%
Infectious Mononucleosis 1.4%
Pharyngitis Streptococcal 1.4%
Pyrexia 1.4%
Drug Exposure During Pregnancy 10.5%
Rotator Cuff Syndrome 10.5%
Urticaria 10.5%
Visual Impairment 10.5%
Blood Creatine Phosphokinase Increased 5.3%
Drug Hypersensitivity 5.3%
Eosinophilic Pneumonia 5.3%
Gastric Disorder 5.3%
Haematemesis 5.3%
Myopathy 5.3%
Pancreatitis 5.3%
Pneumonia 5.3%
Rash Erythematous 5.3%
Renal Failure 5.3%
Swollen Tongue 5.3%
Concomitant
Osteoporosis 33.3%
Bronchitis 16.7%
Multiple Myeloma 16.7%
Nasopharyngitis 16.7%
Postoperative Ileus 16.7%
Arthralgia 16.7%
Colon Cancer 16.7%
Faeces Discoloured 16.7%
Pain 16.7%
Palpitations 16.7%
Skin Exfoliation 16.7%
Interacting
Drug Use For Unknown Indication 83.3%
Pneumonia 16.7%
Drug Toxicity 100.0%